This chemical is primarily utilized as a chiral ligand in asymmetric catalysis, particularly in transition metal-catalyzed reactions. Its application is significant in the synthesis of enantiomerically pure compounds, which are crucial in the pharmaceutical industry for producing drugs with high stereoselectivity. The compound's structure, featuring a diphenylphosphino group and a sulfinamide moiety, allows it to effectively coordinate with metal centers, enhancing the enantioselectivity of catalytic processes. It is often employed in asymmetric hydrogenation, C-C bond formation, and other transformations where precise control over stereochemistry is required. Additionally, its methoxyphenyl group can influence the electronic properties of the ligand, further optimizing its performance in specific catalytic systems. This makes it a valuable tool in the development of chiral intermediates and active pharmaceutical ingredients (APIs).